128 related articles for article (PubMed ID: 28403546)
21. miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.
Zhai L; Ma C; Li W; Yang S; Liu Z
Mol Carcinog; 2016 Dec; 55(12):1990-2000. PubMed ID: 26618772
[TBL] [Abstract][Full Text] [Related]
22. Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.
Wetmur JG
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):215-9. PubMed ID: 7843101
[TBL] [Abstract][Full Text] [Related]
23. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
24. High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
Zhang C; Han Y; Huang H; Qu L; Shou C
Breast Cancer Res Treat; 2014 Sep; 147(2):265-81. PubMed ID: 25129343
[TBL] [Abstract][Full Text] [Related]
25. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.
Wang SH; Zhang MD; Wu XC; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Sep; 37(9):12867-12875. PubMed ID: 27449039
[TBL] [Abstract][Full Text] [Related]
27. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
29. [delta-Aminolevulinate dehydratase deficiency].
Fujita H; Ishida N; Akagi R
Nihon Rinsho; 1995 Jun; 53(6):1408-17. PubMed ID: 7616655
[TBL] [Abstract][Full Text] [Related]
30. Decrease of hepatic delta-aminolevulinate dehydratase activity in an animal model of fatigue.
Tahara T; Tanaka M; Nozaki S; Jin G; Onoe H; Watanabe Y
Biochem Biophys Res Commun; 2007 Feb; 353(4):1068-73. PubMed ID: 17204241
[TBL] [Abstract][Full Text] [Related]
31. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
32. Import of host delta-aminolevulinate dehydratase into the malarial parasite: identification of a new drug target.
Bonday ZQ; Dhanasekaran S; Rangarajan PN; Padmanaban G
Nat Med; 2000 Aug; 6(8):898-903. PubMed ID: 10932227
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer.
Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L
Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079
[TBL] [Abstract][Full Text] [Related]
34. The centrality of PBGD expression levels on ALA-PDT efficacy.
Schauder A; Feuerstein T; Malik Z
Photochem Photobiol Sci; 2011 Aug; 10(8):1310-7. PubMed ID: 21655622
[TBL] [Abstract][Full Text] [Related]
35. Metals control activity and expression of the heme biosynthesis enzyme delta-aminolevulinic acid dehydratase in Bradyrhizobium japonicum.
Chauhan S; Titus DE; O'Brian MR
J Bacteriol; 1997 Sep; 179(17):5516-20. PubMed ID: 9287008
[TBL] [Abstract][Full Text] [Related]
36. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
[TBL] [Abstract][Full Text] [Related]
37. Modifying effects of δ-Aminolevulinate dehydratase polymorphism on blood lead levels and ALAD activity.
Mani MS; Kunnathully V; Rao C; Kabekkodu SP; Joshi MB; D'Souza HS
Toxicol Lett; 2018 Oct; 295():351-356. PubMed ID: 30025905
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
Li Y; Su X; Pan H
Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
[TBL] [Abstract][Full Text] [Related]
39. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
[TBL] [Abstract][Full Text] [Related]
40. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
